Navigation Links
$1.3M NIH grant to fund Parkinson's disease study
Date:5/28/2008

BINGHAMTON, NY -- A Binghamton University researcher will receive $1.33 million from the National Institutes of Health to support Parkinson's research that will focus not only on the treatment of the disease but also in the side effects of treatment.

"Parkinson's disease patients have trouble with movement," said Christopher Bishop, assistant professor of psychology. "They move more slowly. They have rigidity in their limbs. They have balance problems and tremors."

The cardinal symptoms are a result of a deficit of dopamine in the brain. Dopamine is a neurotransmitter that's essential for movement; it also plays an important role in behavior, cognition and sleep. In Parkinson's patients, neurons in the brain that make dopamine die. Scientists still aren't sure why; genetic factors are believed to play only a small role.

This deficit of dopamine can be reversed with treatment using a compound called L-DOPA, which has been the gold standard in Parkinson's treatment for about 50 years. The brain converts L-DOPA into dopamine, which is why it's an effective replacement therapy for patients. For five to 10 years, this treatment works well. "The problem," Bishop explained, "is that Parkinson's is a progressive disease. You lose more and more of these neurons as time goes on, so therapeutically, doses of L-DOPA must increase."

While that works for some people, many patients suffer troubling side effects as the dosage increases. "By year 10," Bishop said, "as many as 90 percent of patients will start to suffer from motor fluctuations and something called L-DOPA-induced dyskinesia. So you go from a state of no treatment where you're not moving well, to a state where the drug is working well and you're moving fluidly, to a point where L-DOPA doses are very high and you're producing these abnormal, involuntary movements."

The excessive movements patients display aren't a result of the Parkinson's disease, but rather a symptom of the chronic L-DOPA. And patients can't simply stop taking L-DOPA; if they do, they face a nearly "frozen" life with incredibly limited ability to move.

Bishop and his colleagues at Wayne State University's medical school and the Veterans Administration hospital in Chicago hope to find a way to reduce dyskinesia and suppress these movements. There are very few treatments available, in part because how dyskinesia develops is still a mystery.

"We are beginning to believe that dyskinesia is actually the inability to suppress motor memories as a result of the drug's stimulation," Bishop said.

One possible treatment relates to glutamate, a neurotransmitter in the brain that can play a role in these memory processes, helping to lay down new pathways for motor memories. The five-year grant from the National Institute for Neurological Disorders and Stroke will allow Bishop and his team to study serotonin compounds that reduce glutamate following L-DOPA treatment. Bishop's work has also been supported by the American Parkinson's Disease Association.

According to Bishop, Parkinson's is an increasingly urgent medical concern. Roughly 1 million people in the United States have Parkinson's; 50,000 more Americans are diagnosed with the disease each year.

"That's only going to increase as our population ages," Bishop said. "This is not something that's going away.


'/>"/>

Contact: Gail Glover
gglover@binghamton.edu
607-777-2174
Binghamton University
Source:Eurekalert  

Related medicine news :

1. Cornell receives federal grants to create fabrics to render toxic chemicals harmless
2. Video/Online Games for Health: 12 Research Teams From Across U.S. To Receive Major Grants
3. ClearWay Minnesota(SM) Board Approves $1.4 Million in New Grants to Reduce Tobaccos Harm
4. Five Heart Heroines Honored With Cheerios Sisters Saving Hearts(TM) Grants
5. Research Grant to Fund Free Surgeries for Women Suffering From Blocked Fallopian Tubes
6. Forty-Two Free Clinics Across State Share $1 Million in Grants From Blue Cross Blue Shield of Michigan
7. Healthy Farms, Healthy Schools Grant Applications Available
8. International Diabetes Federation gives grant to diabetes screening & prevention program in Vietnam
9. Kresge Foundation Employs New Funding Methods in its First Quarter Grant Awards of Nearly $43 Million
10. International Diabetes Federation gives grant to metabolic syndrome research project in Australia
11. Video: Pediatric Brain Tumor Foundation Gives $6 Million Grant to Duke
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
$1.3M NIH grant to fund Parkinson's disease study
(Date:5/24/2016)... (PRWEB) , ... May 24, 2016 , ... ... for physical disease or injury that focuses on repairing the musculoskeletal and neuromuscular ... With an emphasis on functional restoration, NYDNRehab began providing treatments for physical therapy ...
(Date:5/24/2016)... ... May 24, 2016 , ... Backed by decades of experience, ... job, ensuring the best suited solution to meet regulatory requirements. Their professional staff ... lab in Istanbul. , Metroloji Okulu specializes in MadgeTech’s line of medical and ...
(Date:5/24/2016)... (PRWEB) , ... May 24, 2016 , ... ... egg freezing, today announced the official relaunch of its community and education hub ... frozen eggs. Eggsurance's mission is to create a safe and welcoming place for ...
(Date:5/24/2016)... ... May 24, 2016 , ... The Radiosurgery Society ... of radiosurgery, is recognizing five medical residents and students for their outstanding contributions ... (SBRT). The awards will be presented at the 2016 SRS/SBRT Scientific Meeting taking ...
(Date:5/24/2016)... ... May 24, 2016 , ... The ... 9.3 million people, or 10% over last year, according to data in the ... group policies was comparatively stable, with a slight decrease in risk-based groups and ...
Breaking Medicine News(10 mins):
(Date:5/23/2016)... -- Experts from various countries ... role of technology in innovative healthcare ... International Conference of VPS-Penn Medicine opened in Abu ... Sheikh Nahyan bin Mubarak Al Nahyan, Minister of Culture and ... provide personalized medicine and tailor-made healthcare in disease treatment and ...
(Date:5/22/2016)... 2016 DS Biopharma (DS) ... anti-inflammatory compound DS102 in chronic obstructive pulmonary disease ... (NASH) patients. Recent DS preclinical data ... tissue and has bronchodilatory, anti-inflammatory and anti-fibrotic properties ... Company will publish further detail on these findings ...
(Date:5/20/2016)... , May 20, 2016 According ... driver is the increasing demand for affordable healthcare solutions as ... steadily on the rise. In countries like the US, the ... In the US, the consumer price index inflation rate stood ... inflation rate moved up to 3.62% during the same time ...
Breaking Medicine Technology: